Search results for "Penile Erection"

showing 10 items of 15 documents

Sexual Function and Quality of Life in Adult Male Individuals with Exstrophy-Epispadias Complex—a Survey of the German CURE-Network

2017

Objective To investigate sexual function and quality of life (QoL) in adult male individuals with exstrophy-epispadias complex (EEC). Data from the German Network for Congenital Urorectal Malformations (CURE-Net) were used. Patients and Methods Fifty-one male participants (≥18 years) recruited by CURE-Net between 2009 and 2012 were re-contacted per mail and asked to fill out 4 questionnaires including International Index of Erectile Function (IIEF-5), Cologne Assessment of Erectile Dysfunction (KEED), the Short-Form 36 (SF-36), and one self-designed questionnaire about their medical history, current health status, and sexual experience. The SF-36 results were compared with general German po…

AdultMalePediatricsmedicine.medical_specialtyEpispadiasUrology030232 urology & nephrologyUrinary incontinenceSubgroup analysisDiagnostic Self EvaluationYoung Adult03 medical and health sciences0302 clinical medicineErectile DysfunctionQuality of lifeGermanymedicineHumansMedical historySex organGynecologybusiness.industryPenile ErectionBladder Exstrophymedicine.diseaseBladder exstrophySexual Dysfunction PhysiologicalErectile dysfunction030220 oncology & carcinogenesisQuality of Lifemedicine.symptomSexual functionbusinessUrology
researchProduct

Effects of yohimbine on sexual experiences and nocturnal penile tumescence and rigidity in erectile dysfunction.

1996

The therapeutic effect of the alpha 2-antagonist yohimbine in erectile dysfunction was studied in a double-blind placebo-controlled design. Thirty-one male patients underwent extensive clinical, urological, and psychiatric diagnosis and were dichotomically classified into an organic and a nonorganic subgroup. Following a 1-week placebo run-in period, patients were randomly assigned to a placebo or a verum group (yohimbine 15 mg daily) for a treatment period of 7 weeks. The Clinical Global Impression (CGI) scale was used as the primary efficacy parameter. Additionally, nocturnal penile tumescence and rigidity (NPTR) were measured. Global assessment of erectile function applying the CGI scale…

AdultMalePolysomnographyPolysomnographyPlacebolaw.inventionPlacebosAlkaloidsArts and Humanities (miscellaneous)Randomized controlled trialDouble-Blind MethodlawmedicineHumansSexual Dysfunctions PsychologicalGeneral Psychologymedicine.diagnostic_testPenile ErectionTherapeutic effectYohimbineMiddle Agedmedicine.diseaseYohimbineErectile dysfunctionAnesthesiaNocturnal penile tumescenceClinical Global ImpressionPsychologySleepmedicine.drugArchives of sexual behavior
researchProduct

Comparison of selective internal iliac pharmaco-angiography, penile brachial index and duplex sonography with pulsed Doppler analysis for the evaluat…

1990

AbstractBetween July 1987 and February 1988 selective internal iliac angiography was performed before and after intracavernous injection of papaverine plus phentolamine in 43 patients with erectile dysfunction. In 63% of the patients stenosis or occlusion of the pudendal artery was found. The penile brachial index was calculated and duplex sonography with pulsed Doppler analysis was performed in 23 patients. Angiography and penile brachial index correlated in only 39% of the patients, whereas selective internal iliac angiography and duplex sonography correlated in 91% (21 of 23). In 2 patients duplex sonography with pulsed Doppler analysis rendered better information about penile arterial p…

AdultMalemedicine.medical_specialtyBrachial ArteryUrologyHemodynamicsIntracavernous injectionBlood PressureIliac ArteryErectile Dysfunctionmedicine.arteryPapaverineOcclusionmedicineHumansInternal pudendal arteryAgedUltrasonographyPapaverinemedicine.diagnostic_testbusiness.industryPenile ErectionBlood Pressure DeterminationMiddle Agedmedicine.diseaseRadiographyStenosisErectile dysfunctionEvaluation Studies as TopicAngiographyRadiologybusinessmedicine.drugPenisThe Journal of urology
researchProduct

Effects of Clomipramine on Sleep EEG and Nocturnal Penile Tumescence

1988

The effects of the tricyclic antidepressant clomipramine on sleep EEG and nocturnal penile tumescence (NPT) were investigated during a long-term study in a normal male control subject. During 21 consecutive days the subject received first placebo for 3 days, then stepwise increasing dosages of clomipramine for 10 days, and finally placebo after withdrawal for 8 days. Under clomipramine, rapid eye movement (REM) sleep was suppressed markedly; an REM rebound occurred after withdrawal. Awake and stages 1 and 2 increased while slow wave sleep was diminished under clomipramine. Those non-REM parameters returned to baseline values after drug cessation. NPT was reduced simultaneously with REM slee…

AdultMalemedicine.medical_specialtyClomipramineEjaculationSexual BehaviorRapid eye movement sleepPlaceboREM reboundInternal medicinemedicineHumansPharmacology (medical)Slow-wave sleepPenile ErectionElectroencephalographymedicine.diseasePsychiatry and Mental healthEndocrinologyErectile dysfunctionNocturnal penile tumescenceAnesthesiaClomipramineSleepPsychologymedicine.drugJournal of Clinical Psychopharmacology
researchProduct

Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studie…

1993

The effects of the optically active enantiomers of oxaprotiline (OXP), R(-) OXP and S(+) OXP, on depressive symptomatology and the sleep EEG were investigated in two separate exploratory studies. In addition, the neuroendocrine profile of both compounds was characterized in normal controls. In the patients treated with a daily oral dose of 150 mg S(+) OXP we found a Hamilton depression score that decreased from 29.1 +/- 1.8 (SEM) on day 0 to 14.7 +/- 3.2 on day 28 (P0.01). Six patients were judged to be full responders (HAMD score 0-7 points), three were improved (HAMD score 8-15) and four were nonresponders (HAMD score16). The therapeutic effect achieved with 150 mg R(-) OXP daily was less…

AdultMalemedicine.medical_specialtyHydrocortisoneSleep REMchemistry.chemical_compoundNorepinephrineInternal medicineHamdmedicineHumansPharmacology (medical)SecretionTestosteroneBiological PsychiatryTestosteroneAgedPharmacologyPsychiatric Status Rating ScalesDepressive DisorderNeurosecretionPenile ErectionTherapeutic effectOxaprotilineElectroencephalographyStereoisomerismMiddle AgedProlactinAntidepressive AgentsProlactinPsychiatry and Mental healthEndocrinologyNeurologychemistryMaprotilineGrowth HormoneEndogenous depressionFemaleNeurology (clinical)EnantiomerPsychologySleepEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Effects of moclobemide on sexual performance and nocturnal erections in psychogenic erectile dysfunction

2001

Rationale and objectives: We tested the hypothesis that the selective reversible MAO-A inhibitor moclobemide has a specific therapeutic effect on erectile dysfunction independent of its antidepressive properties. Methods: In a double-blind placebo controlled study, 12 male outpatients suffering from psychogenic erectile dysfunction without any other psychiatric disorder were investigated. Based on comprehensive diagnosis before the beginning of the study, organic factors relevant for sexual function were excluded. The treatment period was 8 weeks. Half the patients received 450 mg moclobemide during the first week, and 600 mg afterwards; the others received placebo. Apart from assessment of…

AdultMalemedicine.medical_specialtyMonoamine Oxidase InhibitorsMoclobemidePlacebo-controlled studyPlaceboDouble-Blind MethodErectile DysfunctionInternal medicineMoclobemidemedicineHumansPsychogenic diseasePharmacologyAnalysis of VariancePenile ErectionTherapeutic effectElectroencephalographyMiddle Agedmedicine.diseaseSurgeryErectile dysfunctionClinical Global ImpressionPsychologySexual functionmedicine.drugPsychopharmacology
researchProduct

Examination and treatment of sleep-related painful erections--a case report.

1989

The case of a patient with sleep-related painful erections is described. Insomnia and a slight depressive syndrome occurred along with a long history of this disorder. No physical abnormality was found. At a baseline recording of sleep electroencephalography (EEG) and nocturnal penile tumescence (NPT), a disturbed sleep pattern and impaired NPT were recorded. Attempts to treat the disorder with diazepam, amitriptyline, trimipramine, and biperidene did not prompt a stable improvement of the disorder, but a dosage of 25 mg clozapine was sufficient to achieve normalized sleep architecture, remission of the depressive symptomatology, and normalization of NPT. It is likely that marked sedation i…

AdultMalemedicine.medical_specialtySedationAdministration OralPainElectroencephalographyArts and Humanities (miscellaneous)DibenzazepinesSleep Initiation and Maintenance DisordersInsomniamedicineHumansAmitriptylinePsychiatryClozapineEvoked PotentialsGeneral PsychologyClozapinemedicine.diagnostic_testPenile ErectionElectroencephalographyTrimipramineNocturnal penile tumescenceAnesthesiaDisturbed sleep patternSleep Stagesmedicine.symptomPsychologymedicine.drugArchives of sexual behavior
researchProduct

Temporal relationship between nocturnal erections and rapid eye movement episodes in healthy men.

2003

The exact temporal relationship between spontaneous nocturnal erections and rapid eye movement (REM) sleep was studied in healthy men with the aim of creating a basis for a more sophisticated analysis of nocturnal erection measurements in physiological research and clinical applications. The vast majority of erectile events was coupled to REM episodes, where the latency between the beginning of erections and REM episodes showed a large variability. Moreover, a correlation analysis revealed a highly significant decrease of the latency over the course of the night. The time variant properties of the coupling between erections and REM sleep point to more complex dynamics of the central control…

AdultMalemedicine.medical_specialtymedia_common.quotation_subjectPolysomnographyRapid eye movement sleepSleep REMPolysomnographyNocturnalPhysical medicine and rehabilitationInternal medicinemedicineReaction TimeHumansBiological Psychiatrymedia_commonmedicine.diagnostic_testmusculoskeletal neural and ocular physiologyPenile ErectionEye movementElectroencephalographyMiddle Agedmedicine.diseaseCircadian RhythmPsychiatry and Mental healthNeuropsychology and Physiological PsychologyPsychophysiologyEndocrinologyErectile dysfunctionCorrelation analysisPsychologycirculatory and respiratory physiologyVigilance (psychology)PsychophysiologyNeuropsychobiology
researchProduct

Hypertension and Impotence

1991

In a group of 472 impotent patients who were evaluated with pharmacologic duplex sonography, 117 patient (24.8%) had a history of hypertension, 26 of them (22.2%) for more than 10 years. Objective data about the changes in pulsation, diameter and blood flow velocity of the penile arteries after papaverine injection and the resulting erectile response allowed indirect assessment of the penile venous function. Varying degrees of impaired arterial function were diagnosed in 85% of the patients. The duration of hypertension had less deteriorating effects on the penile arterial system than second risk factors such as diabetes mellitus (n = 31) or smoking (n = 26). Patients on antihypertensive me…

MaleVenous leakmedicine.medical_specialtyUrologyErectile tissueVasodilationDiabetes ComplicationsErectile DysfunctionRisk FactorsPapaverineInternal medicineDiabetes mellitusmedicineHumansAntihypertensive AgentsPapaverinebusiness.industryPenile ErectionSmokingBlood flowMiddle Agedmedicine.diseaseSurgeryCompliance (physiology)medicine.anatomical_structureBlood pressureRegional Blood FlowHypertensionCardiologybusinessPenismedicine.drugEuropean Urology
researchProduct

Sildenafil orodispersible film in the treatment of erectile dysfunction after radical prostatectomy: A single‐centre open‐label uncontrolled trial

2020

Phosphodiesterase-5 inhibitors are the first-line therapy for erectile dysfunction (ED) after radical prostatectomy (RP). This single-centre open-label uncontrolled study evaluated the efficacy and safety of the new sildenafil orodispersible film (ODF) in ED treatment after RP. Sildenafil 100 mg ODF was administered twice a week for 3 months to patients under 75 years of age, with a Framingham cardiovascular risk score < 20% and a pre-operative International Index of Erectile Function (IIEF)-5 score ≥ 17, who had undergone open RP between 2016 and 2018. Erectile function was assessed pre-operatively, post-operatively and after treatment through the IIEF-5 score, the Sexual Encounter Prof…

Malemedicine.medical_specialtyPercentileSildenafilUrologymedicine.medical_treatment030232 urology & nephrologyUrologyUncontrolled Studyprostatic neoplasmsSildenafil Citrate03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyErectile DysfunctiontherapeuticsHumansMedicineAdverse effectProstatectomy030219 obstetrics & reproductive medicineFramingham Risk Scorebusiness.industryProstatectomyPenile ErectionOrodispersible filmGeneral MedicinePhosphodiesterase 5 Inhibitorsmedicine.diseaseTreatment OutcomeErectile dysfunctionchemistrybusinessAndrologia
researchProduct